Explore surgical options for metastatic bladder cancer, including radical cystectomy and metastasectomy. Learn how surgery ...

Removing more lymph nodes in the pelvis probably results in fewer deaths from bladder cancer, but may make no difference to death from any cause or the cancer coming back (all measured within five ...

The FDA has granted a priority review to the supplemental Biologics License Application for enfortumab/pembrolizumab to all ...

Detailed price information for Theralase Technologies Inc. (TLT-X) from The Globe and Mail including charting and trades.

US FDA grants priority review to sBLA for Padcev+Keytruda as perioperative treatment for muscle-invasive bladder cancer regardless of cisplatin eligibility: Tokyo Tuesday, April 2 ...

Submission based on statistically significant event-free and overall survival data from the Phase 3 EV-304 trial Building on the existing indication in cisplatin-ineligible ...

Federal health regulators have formally warned ImmunityBio Inc. for making misleading promotional claims about Anktiva, the company’s bladder cancer drug. Dr. Patrick Soon-Shiong, the company’s ...

EV-304 trial. The U.S. Food and Drug Administration (FDA) has granted Priority Review to a supplemental biologics license application for enfortumab vedotin-ejfv (Padcev) in combination with ...

Ovarian cystectomy is a fertility-preserving surgical procedure used to remove ovarian cysts while keeping the healthy ovary ...

FDA grants Priority Review to enfortumab vedotin plus pembrolizumab for cisplatin-eligible MIBC based on KEYNOTE-B15 data showing a 47% reduction in EFS risk.

A team of researchers led by California Institute of Technology computer scientist and mathematician Babak Hassibi says it has created a large language model that radically compresses its size without ...